Effects of rare CYP2C9 alleles on stable warfarin doses in Chinese Han patients with atrial fibrillation

被引:6
|
作者
Wang, Dongxu [1 ]
Dai, Da-Peng [2 ]
Wu, Hualan [1 ]
Chong, Jia [1 ]
Lu, You [1 ]
Yin, Ruoyun [1 ]
Zhao, Xinlong [1 ]
Zhao, Anxu [1 ]
Yang, Jiefu [1 ]
Chen, Hao [1 ]
机构
[1] Beijing Hosp, Cardiovasc Dept, Natl Ctr Gerontol, Beijing 100730, Peoples R China
[2] Beijing Hosp, Natl Ctr Gerontol, Key Lab Geriatr, Beijing 100730, Peoples R China
基金
美国国家科学基金会;
关键词
atrial fibrillation; gene polymorphism; warfarin-dosing algorithm; warfarin; GENETIC-VARIANTS; IN-VITRO; FUNCTIONAL-CHARACTERIZATION; CYP2C9-ASTERISK-13; ALLELE; GENOTYPE; VKORC1; IDENTIFICATION; REQUIREMENT; PHARMACOKINETICS; ANTICOAGULATION;
D O I
10.2217/pgs-2020-0051
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim:Gene polymorphisms are critical in warfarin dosing variation. Here, the role of rareCYP2C9alleles on warfarin doses in Chinese Han patients was investigated.Methods:A retrospective study recruited 681 warfarin treated atrial fibrillation patients. The genetic and clinical data were collected. Dose-related variables were selected by univariate analyses and the warfarin-dosing algorithm was derived by multivariate regression analysis.Results:Three rareCYP2C9alleles (CYP2C9*13, *16 and *60) were associated with lower stable doses. Inclusion of the rareCYP2C9alleles in the prediction model added an extra 3.7% warfarin dose predictive power.Conclusion:CYP2C9*13, *16 and *60 was associated with lower stable warfarin doses in Chinese patients. The algorithm including rareCYP2C9alleles tends to more accurately predict stable warfarin doses.
引用
收藏
页码:1021 / 1031
页数:11
相关论文
共 50 条
  • [1] Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants
    Wang, Dongxu
    Wu, Hualan
    Zhang, Qing
    Zhou, Xiaoyue
    An, Yang
    Zhao, Anxu
    Chong, Jia
    Wang, Shuanghu
    Wang, Fang
    Yang, Jiefu
    Dai, Dapeng
    Chen, Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (10) : 1315 - 1320
  • [2] Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants
    Dongxu Wang
    Hualan Wu
    Qing Zhang
    Xiaoyue Zhou
    Yang An
    Anxu Zhao
    Jia Chong
    Shuanghu Wang
    Fang Wang
    Jiefu Yang
    Dapeng Dai
    Hao Chen
    European Journal of Clinical Pharmacology, 2023, 79 : 1315 - 1320
  • [3] Clinical significance of the series of CYP2C9*non3 variants, an unignorable predictor of warfarin sensitivity in Chinese population
    Wang, Dongxu
    Wu, Hualan
    Dong, Min
    Zhang, Qing
    Zhao, Anxu
    Zhao, Xinlong
    Chong, Jia
    Du, Minghui
    Wang, Yan
    Shi, Haifeng
    Wang, Shuanghu
    Wang, Fang
    Cai, Jianping
    Yang, Jiefu
    Dai, Dapeng
    Chen, Hao
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [4] DNA sensors to assess the effect of VKORC1 and CYP2C9 gene polymorphisms on warfarin dose requirement in Chinese patients with atrial fibrillation
    Huang, Tao-Sheng
    Zhang, Ling
    He, Qiong
    Li, Yu-Bin
    Dai, Zhong-Li
    Zheng, Jian-Rui
    Cheng, Pei-Qi
    He, Yun-Shao
    AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 2017, 40 (01) : 249 - 258
  • [5] Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation
    Zhang, Hongshen
    Ma, Kezhong
    Liu, Wenwei
    Yang, Feng
    Liu, Jianfei
    Zhou, Hanyun
    GENE, 2016, 591 (01) : 80 - 84
  • [6] Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin
    Barros Melo da Silveira, Maria Mariana
    Melo, Leiliandry de Ara
    Ferreira Gomes, Filipe Maia
    Barreto da Rocha Andrade, Leonardo Jose de Cupertino
    Serur, Isabela Paulino
    de Vasconcellos Piscoya, Isabelle Cecilia
    Gueiros, Raposo Marina
    do O, Kleyton Palmeira
    de Lima, Raul Emidio
    Eulalio Brasileiro, Victor Arthur
    Silva Vasconcelos, Luydson Richardson
    Sobral Filho, Dario Celestino
    APPLICATION OF CLINICAL GENETICS, 2019, 12 : 151 - 159
  • [7] Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics
    Jung-woo Bae
    Chang-ik Choi
    Mi-jeong Kim
    Da-hee Oh
    Seul-ki Keum
    Jung-in Park
    Bo-hye Kim
    Hye-kyoung Bang
    Sung-gon Oh
    Byung-sung Kang
    Hyun-joo Park
    Hae-deun Kim
    Ji-hey Ha
    Hee-jung Shin
    Young-hoon Kim
    Han-sung Na
    Myeon-woo Chung
    Choon-gon Jang
    Seok-yong Lee
    Acta Pharmacologica Sinica, 2011, 32 : 1303 - 1308
  • [8] Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics
    Bae, Jung-woo
    Choi, Chang-ik
    Kim, Mi-jeong
    Oh, Da-hee
    Keum, Seul-ki
    Park, Jung-in
    Kim, Bo-hye
    Bang, Hye-kyoung
    Oh, Sung-gon
    Kang, Byung-sung
    Lee, Hye-in
    Lee, Yun-jeong
    Park, Hyun-joo
    Kim, Hae-deun
    Ha, Ji-hey
    Shin, Hee-jung
    Kim, Young-hoon
    Na, Han-sung
    Chung, Myeon-woo
    Han, Soon-young
    Kim, Seung-hee
    Jang, Choon-gon
    Lee, Seok-yong
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (10) : 1303 - 1308
  • [9] A new algorithm to predict warfarin dose from polymorphisms of CYP4F2, CYP2C9 and VKORC1 and clinical variables: Derivation in Han Chinese patients with non valvular atrial fibrillation
    Wei, Meng
    Ye, Fei
    Xie, Dujiang
    Zhu, Yubing
    Zhu, Junrong
    Tao, Yifu
    Yu, Feng
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (06) : 1083 - 1091
  • [10] Warfarin dose requirements in a patient with the CYP2C9*14 allele
    Lee, Yee Ming
    Eggen, Jessica
    Soni, Vinay
    Drozda, Katarzyna
    Nutescu, Edith A.
    Cavallari, Larisa H.
    PHARMACOGENOMICS, 2014, 15 (07) : 909 - 914